DXC

$11.82

Post-MarketAs of Mar 17, 8:00 PM UTC

DXC Technology Company, together with its subsidiaries, provides information technology services and solutions in the United States, the United Kingdom, the Rest of Europe, Australia, and internationally.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

AAPLMSFTGOOGL

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$11.82
Potential Upside
300.6%
Whystock Fair Value$47.35
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorTechnology
IndustryInformation Technology Services

DXC Technology Company, together with its subsidiaries, provides information technology services and solutions in the United States, the United Kingdom, the Rest of Europe, Australia, and internationally. It operates in two segments: Global Business ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.06B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
5.14
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.04
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
12.93%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.19

Recent News

Simply Wall St.
Mar 13, 2026

Is There Now An Opportunity In DXC Technology (DXC) After Prolonged Share Price Weakness

If you are wondering whether DXC Technology is a bargain or a value trap at its current share price, looking closely at what you get for each dollar invested becomes crucial. The stock last closed at US$11.94, with returns of 9.5% decline over 7 days, 18.2% decline over 30 days, 15.2% decline year to date, 29.1% decline over 1 year, 49.1% decline over 3 years, and 57.6% decline over 5 years, which may have shifted how investors view its risk and potential. Recent news coverage around DXC...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Insider Monkey
Mar 12, 2026

L3Harris Technologies, Inc. (LHX) Announces Appointment of Ken Sharp as SVP and CFO

L3Harris Technologies, Inc. (NYSE:LHX) is among the 10 Best Aerospace Dividend Stocks to Buy. On March 2, the company announced the appointment of Ken Sharp as Senior Vice President and Chief Financial Officer. He will assume charge from March 16. Sharp brings more than three decades of experience in defense and technology firms, having previously […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 9, 2026

1 Oversold Stock Ready to Bounce Back and 2 That Underwhelm

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 6, 2026

GEO Group, MillerKnoll, Benchmark, Knowles, and DXC Stocks Trade Down, What You Need To Know

A number of stocks fell in the afternoon session after a dismal February jobs report revealed an unexpected drop in employment, fueling concerns about the health of the economy.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Simply Wall St.
Mar 3, 2026

A Look At DXC Technology (DXC) Valuation As Dual‑Track AI Plan Is Outlined At Morgan Stanley Conference

DXC Technology (DXC) shares have come into focus after management used the Morgan Stanley Technology, Media & Telecom Conference to explain a dual-track plan centered on AI-enhanced legacy services and continued operational cleanup. See our latest analysis for DXC Technology. The latest conference comments arrive after a mixed stretch for DXC, with a 7 day share price return of 2.87% contrasting with a 30 day share price decline of 15.52% and a 1 year total shareholder return decline of...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.